Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-118927
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:22
Documents
1
Group Members
FAIRMOUNT HEALTHCARE FUND II L.P.PETER HARWINTOMAS KISELAK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2427721d1_sc13ga.htm SC 13G/A 108756
  Complete submission text file 0001104659-24-118927.txt   110501
Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Filed by) CIK: 0001802528 (see all company filings)

EIN.: 364841215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92116 | Film No.: 241462492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)